Aviva PLC Has $11.65 Million Stock Position in DocuSign, Inc. (NASDAQ:DOCU)

Aviva PLC reduced its holdings in DocuSign, Inc. (NASDAQ:DOCU) by 58.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 129,480 shares of the company’s stock after selling 183,715 shares during the period. Aviva PLC’s holdings in DocuSign were worth $11,645,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Kestra Investment Management LLC bought a new position in DocuSign during the fourth quarter valued at about $30,000. Modus Advisors LLC bought a new stake in shares of DocuSign during the fourth quarter valued at approximately $36,000. First Horizon Advisors Inc. raised its stake in shares of DocuSign by 102.6% in the fourth quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock valued at $36,000 after purchasing an additional 201 shares in the last quarter. Avion Wealth lifted its position in DocuSign by 309.2% in the fourth quarter. Avion Wealth now owns 487 shares of the company’s stock worth $43,000 after purchasing an additional 368 shares during the period. Finally, Avior Wealth Management LLC boosted its stake in DocuSign by 36.5% during the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock worth $49,000 after buying an additional 145 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Jefferies Financial Group cut their price target on shares of DocuSign from $115.00 to $105.00 and set a “buy” rating for the company in a research note on Monday, March 31st. JPMorgan Chase & Co. raised DocuSign from an “underweight” rating to a “neutral” rating and increased their target price for the stock from $70.00 to $75.00 in a report on Monday, March 10th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $90.00 price target on shares of DocuSign in a research note on Friday, March 14th. Wedbush reiterated a “neutral” rating and set a $100.00 price objective on shares of DocuSign in a research note on Friday, March 14th. Finally, Wells Fargo & Company boosted their target price on shares of DocuSign from $70.00 to $73.00 and gave the company an “underweight” rating in a research note on Friday, March 14th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $95.83.

Insider Transactions at DocuSign

In other DocuSign news, Director Teresa Briggs sold 534 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $87.41, for a total value of $46,676.94. Following the completion of the transaction, the director now owns 8,270 shares in the company, valued at approximately $722,880.70. This represents a 6.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider James P. Shaughnessy sold 7,500 shares of the firm’s stock in a transaction on Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total value of $609,825.00. Following the transaction, the insider now owns 45,875 shares of the company’s stock, valued at $3,730,096.25. The trade was a 14.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 57,851 shares of company stock valued at $4,911,319. 1.66% of the stock is currently owned by company insiders.

DocuSign Stock Performance

DocuSign stock opened at $70.35 on Wednesday. The stock has a market cap of $14.25 billion, a PE ratio of 14.51, a price-to-earnings-growth ratio of 6.94 and a beta of 1.20. The firm’s 50-day simple moving average is $84.56 and its 200 day simple moving average is $82.45. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86.

DocuSign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.02. The firm had revenue of $776.25 million for the quarter, compared to analysts’ expectations of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.76 EPS. As a group, analysts predict that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.